{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 23
    }
  },
  "results": [
    {
      "update_type": "Revised",
      "initial_posting_date": "12/15/2021",
      "package_ndc": "0009-3475-03",
      "generic_name": "Methylprednisolone Acetate Injection",
      "contact_info": "844-646-4398",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
      "openfda": {
        "application_number": [
          "NDA011757"
        ],
        "brand_name": [
          "DEPO-MEDROL"
        ],
        "generic_name": [
          "METHYLPREDNISOLONE ACETATE"
        ],
        "manufacturer_name": [
          "Pharmacia & Upjohn Company LLC"
        ],
        "product_ndc": [
          "0009-3475",
          "0009-3073"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRA-ARTICULAR",
          "INTRALESIONAL",
          "INTRAMUSCULAR",
          "SOFT TISSUE"
        ],
        "substance_name": [
          "METHYLPREDNISOLONE ACETATE"
        ],
        "rxcui": [
          "1743779",
          "1743781",
          "1743855",
          "1743856"
        ],
        "spl_id": [
          "742fcec7-8db3-4cc6-b276-42587a993810"
        ],
        "spl_set_id": [
          "9a7b3837-e038-48bf-97e9-78ad463760dc"
        ],
        "package_ndc": [
          "0009-3073-01",
          "0009-3073-03",
          "0009-3475-01",
          "0009-3475-03"
        ],
        "unii": [
          "43502P7F0P"
        ]
      },
      "update_date": "10/21/2026",
      "therapeutic_category": [
        "Rheumatology"
      ],
      "dosage_form": "Injection",
      "presentation": "Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03)",
      "company_name": "Pfizer Inc.",
      "shortage_reason": "Other",
      "status": "Current"
    }
  ]
}